Please assess the completion status of the following clinical trial:

Trial Title: Study of Nitazoxanide Suspension in the Treatment of Diarrhea Caused by Enteric Viruses in Children

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE2/PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Age \<12 years.~* Patients with diarrhea (defined as 3 or more stools per day with liquid or semi-solid consistency, the number and consistency of stools being unusual for that person).~* Stool positive for adenovirus, norovirus or rotavirus by ELISA.~Exclusion Criteria:~* Females who are pregnant, suspected of being pregnant or breastfeeding.~* Other identified causes of diarrhea at screening.~* Serious systemic disorders incompatible with the study.

- Gender: ALL
- Minimum Age: None
- Maximum Age: 11 Years
- Healthy Volunteers: f

Study Arms:
- Nitazoxanide (Type: ACTIVE_COMPARATOR): 7.5mg/kg (age under 12 months), 5 mL (100mg nitazoxanide; age 1-3 years), 10 mL (200mg nitazoxanide; age 4-11 years) twice daily x 3 days
- Placebo (Type: PLACEBO_COMPARATOR): 7.5mg/kg (age under 12 months), 5 mL (100mg nitazoxanide; age 1-3 years), 10 mL (200mg nitazoxanide; age 4-11 years) twice daily x 3 days

Based on this trial design, predict the completion outcome and termination type (if applicable).